Clinical role of serum pre-B cell colony-enhancing factor in ventilated patients with sepsis and acute respiratory distress syndrome

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 10, 2013, Pages 760-765

  Lee, Kwangha ^a   Huh, Jin Won ^b   Lim, Chae Man ^b   Koh, Younsuck ^b   Hong, Sang Bum ^b  

^a Pusan National University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute respiratory distress syndrome; Pre B cell colony enhancing factor; Sepsis

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS; SEPSIS; SURVIVOR; VENTILATED PATIENT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROGNOSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SERUM; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84884372455     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.797600     Document Type: Article

References (23)

1. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I . Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor . Mol Cell Biol 1994; 14 : 1431-7 .
2. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Bluher M, Stumvoll M, et al . Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine . Clin Sci (Lond) 2008; 115 : 13-23 .
3. Chen M P, Chung F M, Chang D M, Tsai J C, Huang H F, Shin SJ, et al . Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus . J Clin Endocrinol Metab 2006; 91 : 295-9 .
4. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al . Visfatin: a protein secreted by visceral fat that mimics the effects of insulin . Science 2005; 307 : 426-30 .
5. Luk T, Malam Z, Marshall J C. P re-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity . J Leukoc Biol 2008; 83 : 804-16 .
6. Jia S H, Li Y, Parodo J, Kapus A, Fan L, Rotstein O D, et a l . Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental infl ammation and clinical sepsis . J Clin Invest 2004; 113 : 1318-27 .
7. Ye S Q, Simon B A, Maloney J P, Zambelli-Weiner A, Gao L, Grant A, et al . Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury . Am J Respir Crit Care Med 2005; 171 : 361-70 .
8. Hong SB, Huang Y, Moreno-Vinasco L, Sammani S, Moitra J, Barnard JW, et al . Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury . Am J Respir Crit Care Med 2008; 178 : 605-17 .
9. Liu P, Li H, Cepeda J, Zhang LQ, Cui X, Garcia JG, et al . Critical role of PBEF expression in pulmonary cell infl ammation and permeability . Cell Biol Int 2009; 33 : 19-30 .
10. Gao W, Mao Q, Feng AW, Sun HM, Sun WK, Lu X, et al . Inhibition of pre-B cell colony-enhancing factor attenuates infl ammation and apoptosis induced by pandemic H1N1 2009 in lung endothelium . Respir Physiol Neurobiol 2011; 178 : 235-41 .
11. Lee K A, Gong M N. P re-B cell colony enhancing factor (PBEF) and its clinical correlates with acute lung injury and sepsis . Chest 2011; 140 : 382-90 .
12. Bone RC, Sibbald WJ, Sprung CL. T he ACCP- SCCM consensus conference on sepsis and organ failure . Chest 1992; 101 : 1481-3 .
13. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al . Acute respiratory distress syndrome: the Berlin defi nition . JAMA 2012; 307 : 2526-33 .
14. Diaz JV, Brower R, Calfee CS, Matthay MA. T herapeutic strategies for severe acute lung injury . Crit Care Med 2010; 38 : 1644-50 .
15. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network . N Engl J Med 2000; 342 : 1301-8 .
16. Dellinger R P, Levy M M, Carlet J M, Bion J, Parker MM, Jaeschke R, et al . Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 . Crit Care Med 2008; 36 : 296-327 .
17. Knaus W A, Draper E A, Wagner D P, Zimmerman J E . APACHE II: a severity of disease classifi cation system . Crit Care Med 1985; 13 : 818-29 .
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al . The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure . On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22 : 707-10 .
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation . J Chronic Dis 1987; 40 : 373-83 .
20. Kollef MH, Bock KR, Richards RD, Hearns ML. T he safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia . Ann Intern Med 1995; 122 : 743-8 .
21. Souweine B, Veber B, Bedos JP, Gachot B, Dombret MC, Regnier B, et al . Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments . Crit Care Med 1998; 26 : 236-44 .
22. Michel F, Franceschini B, Berger P, Arnal JM, Gainnier M, Sainty JM, et al . Early antibiotic treatment for BAL-confi rmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures . Chest 2005; 127 : 589-97 .
23. Bernard G R, Artigas A, Brigham K L, Carlet J, Falke K, Hudson L, et al . The American-European Consensus Conference on ARDS. Defi nitions, mechanisms, relevant outcomes, and clinical trial coordination . Am J Respir Crit Care Med 1994; 149 : 818-24